The global study reveals the impact of climate
change on human health.
MANCHESTER, England, Sept. 11,
2024 /PRNewswire/ - Leading global healthcare
communications agency, Havas Lynx, has released a new white paper,
"Climate of Health," addressing the impact climate change is having
on global health. The World Health Organization has declared the
climate crisis one of the biggest global threats to human health,
with one in four deaths attributed to preventable environmental
causes. By 2050, it's estimated that it could cause an
additional 14.5 million deaths and $12.5
trillion worth of economic losses worldwide.
The white paper highlights the impact of climate change on every
medical therapy area, including respiratory disease, oncology,
mental health, cardiovascular disease, women's health, diabetes,
and beyond. It also discusses the rising expectations of healthcare
professionals (HCPs) and patients for the pharmaceutical industry
to take action to address this global state of emergency.
"We are not sustainability experts— and we most certainly
don't have all the answers— but through these findings, we
hope to positively contribute to the ongoing conversation," shared
Claire Knapp, CEO of Havas Lynx.
"We're all on this journey to better understand the scale of the
issue so we can make meaningful improvements for the health of our
planet, and subsequently the health of humanity."
New data from Havas Lynx's proprietary data product, Point.1,
reveals that HCPs are increasingly aware of the climate crisis and
its resulting impact on healthcare:
- 77% of HCPs now recognise the climate crisis poses a risk to
the health of their patients and is therefore an urgent problem
that needs addressing.
- Roughly two-thirds (62%) of HCPs currently believe the climate
crisis is altering the landscape of the patients they treat.
- 41% of HCPs now make clinical decisions with the environment in
mind, by trying to prescribe products from responsible
pharmaceutical brands.
- Plus, over half (52%) are more likely to prescribe a
pharmaceutical product if they know it is environmentally
friendly.
Most importantly, HCP expectations for pharma companies to act
to combat climate change now are growing, with 72% of HCPs
believing pharmaceutical companies should use their influence and
take action to enact tangible change.
Acting to tackle climate change, proprietary Point.1 data found
a direct correlation between climate action and corporate equity.
In 2023, WE Brands in Motion found that outside of product
functionality, corporate reputation is the leading factor in
prescribing habits of HCPs. This proves that actively and
authentically engaging in the climate-health crisis isn't only the
right thing to do, but business critical.
Havas Lynx will use this data to educate and advise clients on
how to move forward in a way that will not only positively impact
their brands, but also the health of their consumers and the world
at large.
To find out more about Climate of Health or to read the full
white paper, visit ClimateofHealth.co.uk.
About Havas Lynx
Havas Lynx is a leading healthcare communications agency, named
one of the top three healthcare agencies in the world by Cannes
Lions, with a full-service global offering and almost 500
multidisciplinary specialists in Manchester, London, and New
York. They bring together fresh perspectives, creative
thinking, and a progressive, collaborative approach to partner with
their clients, healthcare professionals, and patients in finding
solutions for the modern-day healthcare landscape.
Visit the Havas Lynx website for more
information: https://havaslynx.com/.
About Point.1 Point.1, a proprietary data solution
from Havas Lynx, provides one of the most comprehensive global
views of healthcare professional (HCP) attitudes, beliefs,
behaviours, and influences to enable more powerful HCP strategies
and experiences.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/havas-lynx-launches-new-white-paper-climate-of-health-302242351.html
SOURCE Havas Lynx